Music listening for Parkinson's (NCT05505019)
Reduce apathy through personalized music
- Trial ID
- NCT05505019
- Official Title
- The Role of a Personalized Music Intervention Towards Alleviating Apathy in Parkinson's Disease
- Goal
- Reduce apathy through personalized music
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of British Columbia
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- Parkinson Disease, Apathy
- Interventions
- Music listening, Podcast listening
Summary For Families
The goal is to see whether listening to music someone finds rewarding can reduce apathy, the loss of motivation and emotion that many people with Parkinson's experience. Participants will listen to their chosen music while a comparison group listens to podcasts, and researchers will track short- and long-term changes in motivation, effortful activity, and brain responses, especially how hearing areas connect with reward areas and whether dopamine, a brain chemical tied to motivation, is involved. They're enrolling adults 40 to 85 with a clinical diagnosis of Parkinson's who do not have major memory problems or moderate depression and who can safely have brain imaging, so people with certain other neurological conditions or metal implants are excluded.
Locations
- Djavad Mowafghian Centre for Brain Health, Vancouver, British Columbia, Canada
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Music listening. The goal is to see whether listening to music someone finds rewarding can reduce apathy, the loss of motivation and emotion that many people with Parkinson's experience. Participants will listen to their chosen music while a comparison group listens to podcasts, and researchers will track short- and long-term changes in motivation, effortful activity, and brain responses, especially how hearing areas connect with reward areas and whether dopamine, a brain chemical tied to motivation, is involved. They're enrolling adults 40 to 85 with a clinical diagnosis of Parkinson's who do not have major memory problems or moderate depression and who can safely have brain imaging, so people with certain other neurological conditions or metal implants are excluded.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 6 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: PET scan (minimally invasive). Confirm the full schedule with the study coordinator.